Boehringer Ingelheim: Boehringer Ingelheim and MEDS partner to expand access to life-saving treatment

Boehringer Ingelheim, a leading research-driven biopharmaceutical company, has signed a Memorandum of Understanding (MoU) with Mission for Essential Drugs and Supplies (MEDS) to further expand the impact of Boehringer Ingelheim's 'Access to Healthcare' program. The partnership aims to improve access to affordable, life-saving treatment for patients living with type 2 diabetes and hypertension in Kenya [...]Boehringer Ingelheim and MEDS partner to expand access to life-saving treatment first appeared on Bizna Kenya